Clinical Trials Directory

Trials / Completed

CompletedNCT02188836

Electromagnetic Stimulation as Coadjuvant in the Healing of Diaphyseal Femoral Fractures

Electromagnetic Stimulation as Coadjuvant in the Healing of Diaphyseal Femoral Fractures: a Randomized Controlled Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Fundacion Clinica Valle del Lili · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study specifically evaluates the effects of electromagnetic stimulation for diaphyseal femur fractures using a device developed by the investigators. The hypothesis is that patients with femoral diaphysis treated with the electromagnetic stimulation have less non-union after six months than patients treated with a placebo device.

Detailed description

The inclusion criteria were: patients of any sex, age between 18 and 60 years, with a closed fracture in their femoral diaphysis or an open fracture secondary to a low-speed bullet; treated with open or closed reduction and intramedullary reamed blocked nail. Patients were excluded if they had a pathological fracture, an open fracture from another etiology, or if they were treated after 10 days from the day of fracture. 64 patients were included. Randomization took place six weeks after fracture day, allocating participants to either one of two groups: group A (electromagnetic stimulation) or group B (placebo). Each group had a device exactly the same. Patients used the device during one hour every day for eight weeks.

Conditions

Interventions

TypeNameDescription
DEVICEElectromagnetic stimulationElectromagnetic stimulation with a new device produced by the investigators for this study.
DEVICESham stimulationThis is a device that look exactly the same to the electrostimulation device, but that does not generate the electromagnetic field. It is a placebo device.

Timeline

Start date
2008-01-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2014-07-14
Last updated
2022-10-21

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT02188836. Inclusion in this directory is not an endorsement.